TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome
- DOI
- 10.1080/14737140.2026.2756200
- Published
- 2026-11-04
- Container
- Expert Review of Anticancer Therapy
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/14737140.2026.2756200,
title = {TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome},
author = {Laura Stanbery and Daniel Craig and Lauren Rager and Susan Morand and Alexander Nemunaitis and Natalie Nemunaitis and Jaxon Nejedlik and Jae Choi and Richard C. Phinney and John Nemunaitis},
year = {2026},
journal = {Expert Review of Anticancer Therapy},
doi = {10.1080/14737140.2026.2756200},
url = {https://doi.org/10.1080/14737140.2026.2756200}
}RIS
TY - JOUR TI - TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome AU - Laura Stanbery AU - Daniel Craig AU - Lauren Rager AU - Susan Morand AU - Alexander Nemunaitis AU - Natalie Nemunaitis AU - Jaxon Nejedlik AU - Jae Choi AU - Richard C. Phinney AU - John Nemunaitis PY - 2026 JO - Expert Review of Anticancer Therapy DO - 10.1080/14737140.2026.2756200 UR - https://doi.org/10.1080/14737140.2026.2756200 ER -
APA
Stanbery, L., Craig, D., Rager, L., Morand, S., Nemunaitis, A., Nemunaitis, N., Nejedlik, J., Choi, J., Phinney, R. C., & Nemunaitis, J. (2026). TROP2-directed antibody-drug conjugates (ADCs) challenge of predicting clinical outcome. Expert Review of Anticancer Therapy. https://doi.org/10.1080/14737140.2026.2756200
Source records
- crossref · retrieved 2026-11-05T23:24:34.130Z